SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

08 Aug 2023 Evaluate
The sales for the June 2023 quarter moved down to Rs. 291.75 millions as compared to Rs. 311.32 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 53.70  millions from Rs. 59.53 millions ,decline by -9.79%.Operating Profit reported a sharp decline to 80.05 millions from 84.15 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 291.75 311.32 -6.29 291.75 311.32 -6.29 1367.49 1239.80 10.30
Other Income 10.37 11.43 -9.27 10.37 11.43 -9.27 51.23 49.49 3.52
PBIDT 80.05 84.15 -4.87 80.05 84.15 -4.87 354.90 322.04 10.20
Interest 0.74 0.87 -14.94 0.74 0.87 -14.94 3.67 4.35 -15.63
PBDT 79.31 83.28 -4.77 79.31 83.28 -4.77 351.23 317.69 10.56
Depreciation 5.00 5.35 -6.54 5.00 5.35 -6.54 22.59 18.99 18.96
PBT 74.31 77.93 -4.65 74.31 77.93 -4.65 328.64 298.70 10.02
TAX 20.61 18.40 12.01 20.61 18.40 12.01 82.58 75.74 9.03
Deferred Tax 0.59 -0.83 -171.08 0.59 -0.83 -171.08 -2.25 2.96 -176.01
PAT 53.70 59.53 -9.79 53.70 59.53 -9.79 246.06 222.96 10.36
Equity 44.13 45.89 -3.84 44.13 45.89 -3.84 44.13 45.89 -3.84
PBIDTM(%) 27.44 27.03 1.51 27.44 27.03 1.51 25.95 25.98 -0.09

Jenburkt Pharma Share Price

1050.40 24.80 (2.42%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×